Given the positive outcomes reported in prior studies, it is recommended to conduct additional testing on the impact of various forms of Arg, Cit, and CitMal supplementation, including acute and long-term or loading doses, and varying timing of ingestion, on cardiovascular health and athletic performance in various populations (i.e., aerobic and anaerobic athletes, resistance-trained individuals, the elderly, and clinical populations) that may benefit from NS
GLP-1 medications were designed with chronicity in mind
Yes, but: Affordability will prevent many of the people who plan on taking a GLP-1 this yearparticularly Gen Zersfrom having consistent access
Forensic Sci Int 8-24-2007;171(1):67-72
The GH-secretagogue and GHRH receptors are no exception, and a run that never pauses risks a slow fade in response that no amount of extra dose recovers